Company Welgene Biotech Co.,Ltd.

Equities

6661

TW0006661002

Biotechnology & Medical Research

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Company contact information

Sector

Sales per Business

Sector Other Biotechnology & Medical Research

End-of-day quote Taipei Exchange Other stock markets 06:00:00 2024-05-27 pm EDT			5-day change	1st Jan Change
22.5 ^TWD	0.00%		+0.45%	+0.67%

May. 09	Welgene Biotech Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Mar. 14	Welgene Biotech Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

WELGENE BIOTECH CO., LTD. is a Taiwan-based company mainly engaged in the provision of genetic testing services and products. The company focuses on deoxyribonucleic acid (DNA) microarray, Next Generation Sequencing and real-time quantitative polymerase chain reaction (PCR) and other testing technologies, which used in school research units, hospitals and biotech companies. The Company is also engaged in the trading of medical equipment. The company mainly operates in two business segments, including Biotechnology Testing segment and Equipment Trading segment. The Company mainly operates in Taiwan market.

TWD in Million	2022	Weight	2023	Weight	Delta
Biotechnology Testing 76.1 %	242	75.2 %	214	76.1 %	-11.73%
Instrument 23.9 %	80	24.8 %	67	23.9 %	-16.24%

TWD in Million	2022	Weight	2023	Weight	Delta
Taiwan 100.0 %	322	100.0 %	281	100.0 %	-12.85%

Managers	Title	Age	Since
Fu Chien Chen CEO	Chief Executive Officer	-	03-01-20
Ying Jen Chen DFI	Director of Finance/CFO	-	-
I Hsing Lin BRD	Director/Board Member	-	-

Members of the board	Title	Age	Since
Sheng-In Cheng BRD	Director/Board Member	-	17-12-11
Jui Hsun Chen BRD	Director/Board Member	-	17-12-11
Fu Chien Chen CEO	Chief Executive Officer	-	03-01-20
Ying Jen Chen DFI	Director of Finance/CFO	-	-
Jui Chen Lin BRD	Director/Board Member	-	-
I Hsing Lin BRD	Director/Board Member	-	-
Hsiao Min Li BRD	Director/Board Member	-	17-12-11
Wei Wei Peng BRD	Director/Board Member	-	-

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	23,304,000	7,473,248 ( 32.07 %)	0	32.07 %

Welgene Biotech Co., Ltd.

12/F 3 Park Street

115 03, Taipei

http://www.welgene.com.tw

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Other Biotechnology & Medical Research

	1st Jan change	Capi.
WELGENE BIOTECH CO.,LTD.	+0.67%	16.29M
MODERNA, INC.	+54.05%	58.71B
IQVIA HOLDINGS INC.	-2.02%	41.31B
LONZA GROUP AG	+40.01%	39.2B
CELLTRION, INC.	-10.22%	27.4B
ICON PUBLIC LIMITED COMPANY	+13.42%	26.55B
ALNYLAM PHARMACEUTICALS, INC.	-21.60%	18.98B
BIO-TECHNE CORPORATION	+2.89%	12.51B
UNITED THERAPEUTICS CORPORATION	+22.40%	11.94B
MEDPACE HOLDINGS, INC.	+27.49%	12.08B

Other Biotechnology & Medical Research